NPs Basic Information
|
Name |
xyloketal L
|
| Molecular Formula | C15H20O3 | |
| IUPAC Name* |
5-methoxy-3,7,9a-trimethyl-2,3,3a,4-tetrahydrofuro[2,3-b]chromene
|
|
| SMILES |
COc1cc(C)cc2c1CC1C(C)COC1(C)O2
|
|
| InChI |
InChI=1S/C15H20O3/c1-9-5-13(16-4)11-7-12-10(2)8-17-15(12,3)18-14(11)6-9/h5-6,10,12H,7-8H2,1-4H3/t10-,12+,15+/m0/s1
|
|
| InChIKey |
CAVZMGYCLGPRNZ-JVLSTEMRSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
*Note: the IUPAC Name was calculated by STOUT. Reference: PMID:33906675.
Chemical Classification: |
|
|
|---|
——————————————————————————————————————————
NPs Species Source
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
NPs Biological Activity
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
NPs Physi-Chem Properties
| Molecular Weight: | 248.32 | ALogp: | 2.9 |
| HBD: | 0 | HBA: | 3 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 27.7 | Aromatic Rings: | 3 |
| Heavy Atoms: | 18 | QED Weighted: | 0.758 |
——————————————————————————————————————————
NPs ADMET Properties*
ADMET: Absorption
| Caco-2 Permeability: | -4.637 | MDCK Permeability: | 0.00002470 |
| Pgp-inhibitor: | 0.727 | Pgp-substrate: | 0.098 |
| Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.034 |
| 30% Bioavailability (F30%): | 0.238 |
——————————————————————————————————————————
ADMET: Distribution
| Blood-Brain-Barrier Penetration (BBB): | 0.498 | Plasma Protein Binding (PPB): | 93.88% |
| Volume Distribution (VD): | 1.045 | Fu: | 2.63% |
——————————————————————————————————————————
ADMET: Metabolism
| CYP1A2-inhibitor: | 0.214 | CYP1A2-substrate: | 0.916 |
| CYP2C19-inhibitor: | 0.266 | CYP2C19-substrate: | 0.939 |
| CYP2C9-inhibitor: | 0.083 | CYP2C9-substrate: | 0.71 |
| CYP2D6-inhibitor: | 0.034 | CYP2D6-substrate: | 0.915 |
| CYP3A4-inhibitor: | 0.189 | CYP3A4-substrate: | 0.679 |
——————————————————————————————————————————
ADMET: Excretion
| Clearance (CL): | 11.905 | Half-life (T1/2): | 0.258 |
——————————————————————————————————————————
ADMET: Toxicity
| hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.852 |
| Drug-inuced Liver Injury (DILI): | 0.693 | AMES Toxicity: | 0.221 |
| Rat Oral Acute Toxicity: | 0.055 | Maximum Recommended Daily Dose: | 0.063 |
| Skin Sensitization: | 0.176 | Carcinogencity: | 0.902 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.028 |
| Respiratory Toxicity: | 0.507 |
——————————————————————————————————————————
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.
Similar Compounds*
Compounds similar to EMNPD with top10 similarity:
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004831 |  |
0.732 | D0P1FO |  |
0.253 | ||
| ENC002560 |  |
0.724 | D0C1SF |  |
0.250 | ||
| ENC002088 |  |
0.644 | D0F7CS |  |
0.245 | ||
| ENC004755 |  |
0.451 | D09PJX |  |
0.239 | ||
| ENC002710 |  |
0.446 | D0T6RC |  |
0.228 | ||
| ENC004264 |  |
0.347 | D0X5KF |  |
0.228 | ||
| ENC004160 |  |
0.333 | D0L7AS |  |
0.228 | ||
| ENC004161 |  |
0.333 | D0K7LU |  |
0.222 | ||
| ENC004159 |  |
0.333 | D0S5CH |  |
0.218 | ||
| ENC004151 |  |
0.318 | D0D4HN |  |
0.216 | ||